Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05505110Phase 1Recruiting
Phase 1, randomised, double-blind trial in dysbiosis, sponsored by Vanderbilt University Medical Center. Primary endpoint: Feasibility of the RCT at 6 months. Started Nov 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05505110.